Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
2.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 40(4): 446-52, 2015 Apr.
Article in Chinese | MEDLINE | ID: mdl-25931225

ABSTRACT

OBJECTIVE: To explore the treatment and pathophysiology of extra-axil cerebrospinal fluid accumulation aft er skull surgery. METHODS: The treatment of 46 cases of pineal regional tumor was retrospectively studied. RESULTS: The CT showed that all patients had postoperative extra-axil cerebrospinal fluid accumulation in 6 hours after operation. 5 cases displayed symptomatic accumulation of extra-axil cerebrospinal fluid. 1 died 30 days aft er discharge, 4 performed S-P shunt and 3 of them switched to V-P shunt after S-P shunt failed. CONCLUSION: Much more attention should be paid to postoperative accumulation of extra-axil cerebrospinal fluid. Both V-P and S-P are the effective strategies of therapy.


Subject(s)
Cerebrospinal Fluid Shunts , Pinealoma/surgery , Skull/surgery , Humans , Pinealoma/cerebrospinal fluid , Postoperative Period , Retrospective Studies
4.
J Clin Neurosci ; 18(8): 1126-7, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21600775

ABSTRACT

A 20-year-old male with a prior history of germinoma presented 8 years after the initial diagnosis with progressive lower back pain. The preoperative diagnosis was schwannoma based on the appearances of a tumor in the lumbosacral region on MRI; however, histologically, a germinoma "drop" metastasis was seen. This report emphasizes the need for long-term follow-up in patients with germinoma. In addition, this patient is unusual in that the preoperative assessment favored schwannoma.


Subject(s)
Germinoma/pathology , Neurilemmoma/physiopathology , Pinealoma/pathology , Spinal Cord Neoplasms/secondary , Chorionic Gonadotropin, beta Subunit, Human/cerebrospinal fluid , Germinoma/cerebrospinal fluid , Humans , Magnetic Resonance Imaging/methods , Male , Pinealoma/cerebrospinal fluid , Spinal Cord Neoplasms/cerebrospinal fluid , Young Adult , alpha-Fetoproteins/cerebrospinal fluid
5.
J Clin Neurosci ; 18(2): 223-6, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21163658

ABSTRACT

This study was conducted to establish a reference value for cerebrospinal fluid (CSF) human chorionic gonadotropin (hCG) levels. We also evaluated the sensitivity of CSF hCG as a biomarker to detect intracranial ectopic germinomas that arise in rare sites other than the pineal and suprasellar regions. CSF hCG was measured in 201 male patients who had various types of neurological disease (not tumours of germ cell origin or other malignant tumours). A reference value of 1.009 U/L was established, and the CSF hCG level among different age groups was not significantly different. CSF and serum hCG were measured before and after radiotherapy in 14 consecutive patients with intracranial ectopic germinomas. The CSF hCG levels were all above 1.009 U/L before radiotherapy. In male patients, a CSF hCG value above 1.009 U/L suggests abnormal intrathecal hCG secretion. These results demonstrate that the CSF hCG assay is a sensitive method for diagnosing intracranial ectopic germinoma.


Subject(s)
Brain Neoplasms/cerebrospinal fluid , Brain Neoplasms/diagnosis , Chorionic Gonadotropin/cerebrospinal fluid , Germinoma/cerebrospinal fluid , Germinoma/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/cerebrospinal fluid , Brain Neoplasms/etiology , Cerebrospinal Fluid/chemistry , Cerebrospinal Fluid/physiology , Child , Germinoma/etiology , Humans , Male , Middle Aged , Pinealoma/cerebrospinal fluid , Pinealoma/diagnosis , Pinealoma/etiology , Predictive Value of Tests , Radiotherapy/methods , Reference Values , Sensitivity and Specificity , Young Adult
7.
J Pediatr Hematol Oncol ; 31(11): 861-4, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19779380

ABSTRACT

We report a case of a mediastinal seminoma occurring 19 months after the resolution of a pineal germinoma. A 15-year-old boy with headaches and visual changes was diagnosed with a pineal germinoma by biopsy and mildly elevated beta-human chorionic gonadatropin (beta-HCG) in serum and cerebral spinal fluid. Radiation therapy leads to the resolution of his pineal germinoma and normalization of the beta-HCG. A mediastinal seminoma (germinoma) was diagnosed nearly 2 years later because of rising serum beta-HCG. There was no evidence of recurrent central nervous system disease. The patient underwent systemic chemotherapy with the complete resolution of the mediastinal seminoma.


Subject(s)
Germinoma/radiotherapy , Mediastinal Neoplasms/drug therapy , Neoplasms, Second Primary/drug therapy , Pinealoma/radiotherapy , Seminoma/drug therapy , Adolescent , Chorionic Gonadotropin, beta Subunit, Human/blood , Chorionic Gonadotropin, beta Subunit, Human/cerebrospinal fluid , Germinoma/blood , Germinoma/cerebrospinal fluid , Germinoma/pathology , Humans , Male , Mediastinal Neoplasms/blood , Mediastinal Neoplasms/cerebrospinal fluid , Mediastinal Neoplasms/pathology , Neoplasms, Second Primary/blood , Neoplasms, Second Primary/cerebrospinal fluid , Neoplasms, Second Primary/pathology , Pinealoma/blood , Pinealoma/cerebrospinal fluid , Pinealoma/pathology , Seminoma/blood , Seminoma/cerebrospinal fluid , Seminoma/pathology , Time Factors
9.
Pediatr Blood Cancer ; 48(3): 285-91, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16598761

ABSTRACT

BACKGROUND: This Phase II study was designed to determine response to chemotherapy and survival after response-based radiation (RT) in children with CNS germ cell tumors. PROCEDURE: Children with germinomas and normal markers received cisplatin 100 mg/m(2) + etoposide, alternating with vincristine + cyclophosphamide (CPM) 2 g/m(2)/d, for four cycles. Children with nongerminomatous tumors or with abnormal markers received doubled doses of cisplatin and CPM. For germinoma patients in complete response (CR), RT was decreased from 50.4 to 30.6 Gy. High-risk patients received neuraxis RT: 50.4 Gy local + 30.6 Gy neuraxis in CR; 54 Gy local + 36 Gy if less than CR. RESULTS: Of 12 germinoma patients, 4 had cerebrospinal fluid (CSF) human chorionic gonadotropin (HCG) 6.9-21 mIU/ml. Of 14 nongerminomatous patients, HCG in serum or CSF was >50 mIU/ml in 9, alpha-fetoprotein (AFP) abnormal in 9. Four germinoma patients attained CR, six PR, one SD, one not evaluable after resection. Two nongerminomatous patients had CR, three PR, three SD, one PD, four not evaluable after resection; one inadequately treated patient had progressive disease (PD). Both PD patients died; one SD patient died during a seizure. Eleven germinoma patients are PF at median 66 months; one patient in CR refused RT, had PD at 10 months, received RT, and was PF at 56 months. Eleven of 14 nongerminomatous patients were PF at median 58 months. CONCLUSION: Response (germinoma, 91%; nongerminomatous, 55%) and survival are encouraging after this regimen plus response-based RT.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/drug therapy , Cranial Irradiation , Neoadjuvant Therapy , Neoplasms, Germ Cell and Embryonal/drug therapy , Adolescent , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Biomarkers, Tumor/blood , Biomarkers, Tumor/cerebrospinal fluid , Brain Neoplasms/blood , Brain Neoplasms/cerebrospinal fluid , Brain Neoplasms/radiotherapy , Brain Neoplasms/surgery , Child , Child, Preschool , Chorionic Gonadotropin/blood , Chorionic Gonadotropin/cerebrospinal fluid , Cisplatin/administration & dosage , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Disease-Free Survival , Drug Administration Schedule , Etoposide/administration & dosage , Germinoma/blood , Germinoma/cerebrospinal fluid , Germinoma/drug therapy , Germinoma/radiotherapy , Germinoma/surgery , Humans , Infant , Neoplasms, Germ Cell and Embryonal/blood , Neoplasms, Germ Cell and Embryonal/cerebrospinal fluid , Neoplasms, Germ Cell and Embryonal/radiotherapy , Neoplasms, Germ Cell and Embryonal/surgery , Pilot Projects , Pinealoma/blood , Pinealoma/cerebrospinal fluid , Pinealoma/drug therapy , Pinealoma/radiotherapy , Pinealoma/surgery , Risk , Treatment Outcome , Vincristine/administration & dosage , alpha-Fetoproteins/analysis , alpha-Fetoproteins/cerebrospinal fluid
10.
J Clin Neurosci ; 13(2): 257-9, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16503489

ABSTRACT

We report a patient with an immature teratoma of the pineal region with high levels of alpha-fetoprotein (AFP) in serum and cerebrospinal fluid. This is very rare and to the best our knowledge, the second case reported in the literature.


Subject(s)
Pinealoma/metabolism , Teratoma/metabolism , alpha-Fetoproteins/metabolism , Adult , Combined Modality Therapy , Headache/etiology , Humans , Magnetic Resonance Imaging , Male , Neurosurgical Procedures , Pinealoma/cerebrospinal fluid , Pinealoma/therapy , Teratoma/cerebrospinal fluid , Teratoma/therapy , alpha-Fetoproteins/cerebrospinal fluid
11.
J Clin Neurosci ; 12(7): 834-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16198924

ABSTRACT

A 40-year old conscious man developed central neurogenic hyperventilation (CNH). He had tumor dissemination to the brainstem 10 months after undergoing partial removal of a pineal glioblastoma. To the best of our knowledge, this is the first report of CNH caused by the cerebrospinal fluid dissemination of a tumor. The authors suggest that multiple lesions from an infiltrative tumor in the brainstem may give rise to CNH and further our understanding of the pathogenesis of CNH.


Subject(s)
Cerebrospinal Fluid/cytology , Consciousness , Glioblastoma/complications , Hyperventilation/etiology , Pinealoma/complications , Adult , Disease Progression , Glioblastoma/cerebrospinal fluid , Humans , Magnetic Resonance Imaging/methods , Male , Neoplasm Invasiveness , Pinealoma/cerebrospinal fluid
12.
Neurol Neurochir Pol ; 33(5): 1033-44, 1999.
Article in Polish | MEDLINE | ID: mdl-10672556

ABSTRACT

Application of magnetic resonance imaging (MRI) in radiology allows to estimate and analyse pineal gland and pineal region pathology more precisely. We report 47 MRI brain studies of patients in whom pineal cyst was recognized as the only pathologic finding. MRI of the brain was performed because of clinical symptoms as headaches (32%), vertigo (26%) and altered behaviour (13%). Because of the common occurrence of pineal cyst in MRI brain imaging it seems to be important to decide whether these patients need neurosurgical intervention, especially if together with morphologic abnormality definite clinical symptoms exist.


Subject(s)
Cysts/pathology , Pinealoma/pathology , Adolescent , Child , Cysts/cerebrospinal fluid , Cysts/complications , Diagnosis, Differential , Dizziness/diagnosis , Dizziness/etiology , Female , Headache/diagnosis , Headache/etiology , Humans , Magnetic Resonance Imaging , Male , Mental Disorders/diagnosis , Mental Disorders/etiology , Middle Aged , Pinealoma/cerebrospinal fluid , Pinealoma/complications , Retrospective Studies
13.
Int J Radiat Oncol Biol Phys ; 29(5): 1089-94, 1994 Jul 30.
Article in English | MEDLINE | ID: mdl-8083078

ABSTRACT

PURPOSE: The association between the cerebrospinal fluid cytology findings and the clinical features of patients with intracranial germinoma was investigated to determine whether cerebrospinal fluid cytology could be helpful in determining the optimal radiation treatment volume. METHODS AND MATERIALS: Between 1976 and 1992, cerebrospinal fluid cytology was performed in 42 germinoma patients using a cytocentrifugation method. Forty patients received irradiation and 2 received chemotherapy with cisplatin and etoposide. RESULTS: Cerebrospinal fluid cytology was positive in 22 of the 42 patients (52%). Dissemination via cerebrospinal fluid (intraventricular or spinal) was present at the initial diagnosis in eight (36%) of the 22 cytology-positive patients and none of the 20 negative patients. After treatment, cerebrospinal fluid dissemination developed in four (18%) of the cytology-positive patients and one (5%) of the negative patients. Two of the former four patients had received chemotherapy alone as initial treatment. Five patients with positive cytology received irradiation to a smaller volume than the cerebrospinal axis (primary tumor site plus spinal axis in three and whole brain in two), but they have not developed recurrence in the 4 to 14 years since therapy. The 5-year survival rate was 93% for the cytology-positive patients and 94% for the negative patients. CONCLUSION: Cerebrospinal fluid cytology-positive patients have a higher risk of cerebrospinal fluid dissemination and it seems reasonable to give them low-dose (20-24 Gy) prophylactic craniospinal irradiation. When properly irradiated, the prognosis of cytology-positive patients is as good as that of negative patients.


Subject(s)
Brain Neoplasms/cerebrospinal fluid , Brain Neoplasms/radiotherapy , Germinoma/cerebrospinal fluid , Germinoma/radiotherapy , Spinal Cord Neoplasms/cerebrospinal fluid , Spinal Cord Neoplasms/radiotherapy , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/drug therapy , Cerebrospinal Fluid/cytology , Child , Cisplatin/administration & dosage , Combined Modality Therapy , Etoposide/administration & dosage , Female , Germinoma/drug therapy , Humans , Male , Pineal Gland/pathology , Pinealoma/cerebrospinal fluid , Pinealoma/drug therapy , Pinealoma/radiotherapy , Spinal Cord Neoplasms/drug therapy , Teratoma/cerebrospinal fluid , Teratoma/drug therapy , Teratoma/radiotherapy
15.
Cancer ; 56(7 Suppl): 1773-7, 1985 Oct 01.
Article in English | MEDLINE | ID: mdl-2992748

ABSTRACT

Tumor markers are useful in establishing the diagnosis of certain central nervous system tumors, especially germinal tumors of the pineal region. They are not sufficiently specific to be able to replace biopsy for exact diagnosis. They may also be useful for monitoring of therapy, as an indicator of recurrence of the tumor. Cerebrospinal fluid cytology is not generally useful in establishing a specific histologic diagnosis, especially in children, but can help to monitor therapy and predict tumor recurrence. More extensive studies are needed in both areas to define more precisely the role of markers and cytologic studies.


Subject(s)
Brain Neoplasms/diagnosis , Polyamines/cerebrospinal fluid , Spinal Cord Neoplasms/diagnosis , Brain Neoplasms/cerebrospinal fluid , Cerebellar Neoplasms/cerebrospinal fluid , Cerebrospinal Fluid/cytology , Child , Humans , Medulloblastoma/cerebrospinal fluid , Neoplasms, Germ Cell and Embryonal/cerebrospinal fluid , Neuroblastoma/cerebrospinal fluid , Pinealoma/cerebrospinal fluid , Spinal Cord Neoplasms/cerebrospinal fluid
16.
J Neurochem ; 45(3): 815-8, 1985 Sep.
Article in English | MEDLINE | ID: mdl-4031863

ABSTRACT

CSF glutamine concentrations were studied in 12 patients with benign brain tumors (meningioma, craniopharyngioma, or osteofibroma), 12 patients with malignant brain tumors (astrocytoma, medulloblastoma, pinealoblastoma, or chondrosarcoma), 9 patients with noncerebral tumors, and a reference group of 24 patients. The mean +/- SD levels in the benign tumor group (424 +/- 124 microM) were significantly lower (p less than 0.0004) than those in the reference group (642 +/- 195 microM). There was no significant difference between the CSF glutamine concentrations in the malignant cerebral tumor group (643 +/- 210 microM) or noncerebral tumor group (599 +/- 127 microM) and those in the reference group. In patients with benign brain tumors there was indication of an inverse linear relationship between the logarithm of CSF glutamine concentration and tumor diameter.


Subject(s)
Brain Neoplasms/cerebrospinal fluid , Glutamine/cerebrospinal fluid , Meningioma/cerebrospinal fluid , Adolescent , Adult , Astrocytoma/cerebrospinal fluid , Cerebellar Neoplasms/cerebrospinal fluid , Child , Chondrosarcoma/cerebrospinal fluid , Craniopharyngioma/cerebrospinal fluid , Female , Fibroma/cerebrospinal fluid , Humans , Male , Medulloblastoma/cerebrospinal fluid , Meningeal Neoplasms/cerebrospinal fluid , Middle Aged , Osteoma/cerebrospinal fluid , Pinealoma/cerebrospinal fluid , Pituitary Neoplasms/cerebrospinal fluid
17.
Clin Chem ; 30(8): 1358-60, 1984 Aug.
Article in English | MEDLINE | ID: mdl-6744584

ABSTRACT

We measured the concentrations of nine trace elements in cerebrospinal fluid of 11 patients with malignant brain tumors, 11 with benign brain tumors, and 10 control patients, using flameless atomic absorption spectrophotometry. The mean and standard deviation for these concentrations (microgram/L) in the control group were 5.1 +/- 2.9 (silver), 326.6 +/- 171.2 (aluminum), 38.5 +/- 32.2 (gold), 36.6 +/- 23.7 (bismuth), 1.5 +/- 1.3 (cadmium), 39.8 +/- 24.7 (copper), 15.7 +/- 11.5 (lead), 20.9 +/- 3.8 (antimony), and 19.1 +/- 13.3 (selenium). Concentrations of silver and lead were markedly increased in patients with malignant cerebral neoplasms. The malignant-tumor/control patient concentration ratios were 2.31 for silver and 2.11 for lead. We observed no significant differences between the results for the benign tumor patients and the control group.


Subject(s)
Brain Neoplasms/cerebrospinal fluid , Metals/cerebrospinal fluid , Selenium/cerebrospinal fluid , Adolescent , Adult , Astrocytoma/cerebrospinal fluid , Brain Neoplasms/surgery , Child , Chondrosarcoma/cerebrospinal fluid , Craniopharyngioma/cerebrospinal fluid , Female , Humans , Male , Medulloblastoma/cerebrospinal fluid , Meningioma/cerebrospinal fluid , Middle Aged , Pinealoma/cerebrospinal fluid , Spectrophotometry, Atomic
19.
J Neurosurg ; 52(5): 635-41, 1980 May.
Article in English | MEDLINE | ID: mdl-6154788

ABSTRACT

Ventricular cerebrospinal fluid (CSF) levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were determined every 2 to 4 hours over a period of 1 to 4 days in 12 patients, consisting of seven cases of brain tumor, two cases of cerebrovascular disease, and three cases of head injury. The concentrations of HVA and 5-HIAA varied with time in all cases, and significant correlations were found between the two values in eight cases. However, the relationship between variations of HVA and 5-HIAA levels and rhythms of sleep and waking could not be clarified. Both HVA and 5-HIAA concentrations varied at high levels in two patients whose CSF flow was completely blocked by tumor at the site of the fourth ventricle and aqueduct, respectively. On the contrary, in a case with craniopharyngioma in the third ventricle which blocked the bilateral foramina of Monro, although the HVA values were high, the 5-HIAA values varied at low levels. Of five comatose patients, two had cerebrovascular lesions and three had sustained head injury, and, in four of the five, the values of either one or both of HVA and 5-HIAA were low, but in the fifth case the 5-HIAA value was high. Estimation of HVA and 5-HIAA concentrations in ventricular CSF may be a valuable tool in the investigation of brain monoamine metabolism. However, many factors must be considered in the interpretation of results of clinical studies.


Subject(s)
Coma/cerebrospinal fluid , Homovanillic Acid/cerebrospinal fluid , Hydrocephalus/cerebrospinal fluid , Hydroxyindoleacetic Acid/cerebrospinal fluid , Phenylacetates/cerebrospinal fluid , Adolescent , Adult , Brain Diseases/cerebrospinal fluid , Brain Neoplasms/cerebrospinal fluid , Child , Craniopharyngioma/cerebrospinal fluid , Ependymoma/cerebrospinal fluid , Female , Homovanillic Acid/metabolism , Homovanillic Acid/physiology , Humans , Hydroxyindoleacetic Acid/metabolism , Hydroxyindoleacetic Acid/physiology , Male , Middle Aged , Neurilemmoma/cerebrospinal fluid , Pinealoma/cerebrospinal fluid , Serotonin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL